Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0028754 (
obesity
)
124,988
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Childhood
obesity
coincides with increased numbers of circulating classical CD14
++
CD16
-
and intermediate CD14
++
CD16
+
monocytes. Monocytes are key players in the development and exacerbation of atherosclerosis, which prompts the question as to whether the monocytosis in childhood
obesity
contributes to atherogenesis over the years. Here, we dissected the monocyte gene expression profile in childhood
obesity
using an Illumina microarray platform on sorted monocytes of 35 obese children and 16 lean controls.
Obese
children displayed a distinctive monocyte gene expression profile compared to lean controls. Upon validation with quantitative PCR, we studied the association of the top 5 differentially regulated monocyte genes in childhood
obesity
with
obesity
and complexity of coronary atherosclerosis (SYNTAX score) in a cohort of 351 adults at risk for ischemic cardiovascular disease. The downregulation of monocyte IMPDH2 and
TMEM134
in childhood
obesity
was also observed in obese adults. Moreover, downregulation of monocyte
TMEM134
was associated with a higher SYNTAX atherosclerosis score in adults. In conclusion, childhood
obesity
entails monocyte gene expression alterations associated with
obesity
and enhanced complexity of coronary atherosclerosis in adults.
...
PMID:Monocyte gene expression in childhood obesity is associated with obesity and complexity of atherosclerosis in adults. 2920 85